| 1 |
32668455 | Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus. | 2021 Jul 15 |
2 |
| 2 |
32235038 | Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice. | 2020 |
1 |
| 3 |
32701823 | Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance. | 2020 Nov 1 |
2 |
| 4 |
33335931 | Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016. | 2020 Dec |
1 |
| 5 |
31339677 | Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. | 2019 Aug 29 |
4 |